Prosiectau fel Prif Ymchwiliwr
- Developing Stat3 Inhibitors As Effective And Safe Treatments For Triple Negative Breast Cancer (06.01.2020 - 01.04.2023)
- Development of small molecule T-cell activators as novel treatments for bladder cancer (01.11.2020 - 31.12.2021)
- Discovery and development of SPAK and OSR1 kinase inhibitors as novel treatments for ischemic strokes (01.03.2020 - 30.09.2021)
- Discovery of brain-penetrant salicylanilides as potential treatments for Parkinson's disease (01.08.2017 - 31.10.2018)
- Harnessing the immunotherapeutic potential of phosphoantigens and their prodrugs (01.02.2018 - 31.03.2019)